Back to UBS Group AG UBS Group AG

ANTXANTX
Showing 8 of 18 quarters

Position history for UBS Group AGUBS Group AG's holdings in AN2 THERAPEUTICS INC

UBS Group AG holds 74,086 shares of ANTX (AN2 THERAPEUTICS INC), worth $358,576 as of 2026-Q2. The position was increased (+20.7% shares).

Current Value

$358,576

Current Shares

74,086

Total Value Change

+$358,576

Total Shares Change

+74,086

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
74,086
+20.7%
$358,5760.0%$4.84
19
2026-Q1
Increased
61,392
+8.3%
$209,9610.0%$1.06
17
2025-Q4
Decreased
56,668
-0.1%
$64,6010.0%$1.08
0
2025-Q3
Decreased
56,694
-8.6%
$72,0010.0%$1.28
0
2025-Q2
Decreased
62,000
-41.5%
$65,7200.0%$1.08
0
2025-Q1
Decreased
106,021
-37.7%
$144,1890.0%$1.39
0
2024-Q4
New
170,292
-
$235,0030.0%$1.41
35
2024-Q3
Exited
0
-100.0%
$00.0%$1.06
0

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used